קפריסין - יוונית - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

pharmascience international ltd (0000007813) julia house, themistokli dervi 3, nicosia, 1066 - lacosamide - film coated tablets - 100mg - lacosamide (8000003467) 100mg

קפריסין - יוונית - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

pharmascience international ltd (0000007813) julia house, themistokli dervi 3, nicosia, 1066 - lacosamide - film coated tablets - 150mg - lacosamide (8000003467) 150mg

קפריסין - יוונית - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

fresenius kabi hellas single member s.a. (0000012445) andromachis 19, marousi, attica, 151 25 - lacosamide - solution for infusion - 10mg/ml - lacosamide (8000003467) 10mg

יוון - יוונית - Εθνικός Οργανισμός Φαρμάκων

teva pharma b.v., haarlem, the netherlands - dorzolamide hydrochloride, timolol maleate - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ ΜΙΑΣ ΔΟΣΗΣ - (2+0,5)% w/v - ineof00917 - dorzolamide hydrochloride - 22.260000 mg; 0025839752 - timolol maleate - 6.830000 mg - timolol, combinations

יוון - יוונית - Εθνικός Οργανισμός Φαρμάκων

pharma stulln gmbh germany (0000001592) werksstrasse 3, stulln, 92551 - dorzolamide hydrochloride; timolol maleate - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - (20+5)mg/ml - ineof00917 dorzolamide hydrochloride 22.260000 mg; 0025839752 timolol maleate 6.830000 mg - timolol, combinations

האיחוד האירופי - יוונית - EMA (European Medicines Agency)

extrovis eu ltd. - λακοσαμίδη - Επιληψία - Αντιεπιληπτικά, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

האיחוד האירופי - יוונית - EMA (European Medicines Agency)

accord healthcare s.l.u. - λακοσαμίδη - Επιληψία - Αντιεπιληπτικά, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

יוון - יוונית - Εθνικός Οργανισμός Φαρμάκων

generics pharma hellas ΕΠΕ - dorzolamide hydrochloride, timolol maleate - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - (20+5)mg/ml - ineof00917 - dorzolamide hydrochloride - 22.260000 mg; 0025839752 - timolol maleate - 6.830000 mg - timolol, combinations

יוון - יוונית - Εθνικός Οργανισμός Φαρμάκων

teva pharma b.v., utrecht, the netherlands - dorzolamide hydrochloride, timolol maleate - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - (2+0,5)% w/v - ineof00917 - dorzolamide hydrochloride - 22.260000 mg; 0025839752 - timolol maleate - 6.830000 mg - timolol, combinations

יוון - יוונית - Εθνικός Οργανισμός Φαρμάκων

pharmathen international s.a., greece Δερβενακίων 4,, 153 51 153 51, Παλλήνη Αττικής 210.66 66 636 - dorzolamide - ey.dro.sol (ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ) - 2% - dorzolamide 20mg - dorzolamide